| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/29/2005 | CN1631372A Microbial drug material, its preparing method and usage |
| 06/29/2005 | CN1631364A Application of tanshinone óÄA in pharmacy |
| 06/29/2005 | CN1631362A Anti cancer sustained releasing composition and its preparation method |
| 06/29/2005 | CN1208466C Prepn process of sulfogalacto oligose with antitumor activity |
| 06/29/2005 | CN1208460C Application of anti-sense VEGF gene sequence |
| 06/29/2005 | CN1208344C Novel human cell endocytic regulatory protein, its coding sequence and use |
| 06/29/2005 | CN1208343C Trichosanthin mutant |
| 06/29/2005 | CN1208333C Indole derivatives useful for the treatment of osteoporosis |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208323C Alpha-substituted carboxylic acid derivatives |
| 06/29/2005 | CN1208322C Dihydroindole and tetrahydroquinoline derivatives |
| 06/29/2005 | CN1208087C Method and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras |
| 06/29/2005 | CN1208083C Chinese traditional medicine composition curing viscera inflammation, toxin and endocrine disorder |
| 06/29/2005 | CN1208061C Artesunate and dihydroarteannuin medicine preparation for proofing formation of blood vessel and use thereof |
| 06/29/2005 | CN1208055C Use of amino acids for making medicine for treating to insulin-resistance |
| 06/28/2005 | US6912470 Nucleotide sequences coding enzymatic polypeptide for use in the production of anticarcinogenic and infection agents |
| 06/28/2005 | US6911549 Method of preparing a taxol derivative |
| 06/28/2005 | US6911542 Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives |
| 06/28/2005 | US6911532 Vertebrate apoptosis gene: compositions and methods |
| 06/28/2005 | US6911526 Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof |
| 06/28/2005 | US6911471 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| 06/28/2005 | US6911456 Related to organ systems which respond to estrogen agonists or antagonists; in particular, 2-phenyl-3-aroylbenzothiophenes and 1-(alkylaminoethoxy phenyl)-1-phenyl-2-phenylbut-1-enes have wide application as estrogen agonists |
| 06/28/2005 | US6911447 Non-aromatic carbocyclic rings; aromatic carbocyclic rings; non-aromatic heterocyclic rings; aromatic heterocyclic rings; compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 |
| 06/28/2005 | US6911446 Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds |
| 06/28/2005 | US6911443 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 06/28/2005 | US6911440 For the treatment of inflammatory rheumatic/rheumatoid diseases and/or pain, rheumatoid arthritis |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | US6911435 Method of treating leukopenia with adenosine |
| 06/28/2005 | US6911433 O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates |
| 06/28/2005 | US6911431 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
| 06/28/2005 | US6911426 Inhibitor of apoptosis proteins (IAP); survivin |
| 06/28/2005 | US6911424 2′-fluoronucleosides |
| 06/28/2005 | US6911320 Pituitary tumor transforming gene (PTTG), formerly pituitary tumor specific gene (PTTG) |
| 06/28/2005 | US6911319 Methods and kits for detecting protein kinases |
| 06/28/2005 | US6911221 Anti-neoplastic drug |
| 06/28/2005 | US6911211 Pharmaceutical and cosmetic carrier or composition for topical application |
| 06/28/2005 | US6911199 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/28/2005 | CA2332054C Platinum complex, its preparation and therapeutic application |
| 06/28/2005 | CA2146775C Novel vitamin d analogues |
| 06/28/2005 | CA2133831C Low toxicity interleukin-2 analogues for use in immunotherapy |
| 06/24/2005 | CA2454456A1 Amino ceramide-like compounds and therapeutic methods of use |
| 06/24/2005 | CA2454453A1 Amino ceramide-like compounds and therapeutic methods of use |
| 06/23/2005 | WO2005056594A1 Akt ACTIVITY SPECIFICALLY INHIBITING POLYPEPTIDE |
| 06/23/2005 | WO2005056029A1 The traditional chinese medicine preparation for treatment of tumour and method of making and using same |
| 06/23/2005 | WO2005056007A1 The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person |
| 06/23/2005 | WO2005056001A1 A use of khellactone derivatives and the composition comprising the same |
| 06/23/2005 | WO2005055939A2 Vinca derivatives |
| 06/23/2005 | WO2005023232A3 Therapeutic, screening and diagnostic methods based on the effect of cb1 receptor modulation on lymphoproliferative disorders. |
| 06/23/2005 | WO2005014584A9 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis |
| 06/23/2005 | WO2004046094A9 Histone deacetylase inhibitors |
| 06/23/2005 | WO2004028564A8 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 06/23/2005 | US20050137263 e.g., 2-[(4-Ethyl-2-fluorophenyl)amino]-3,4-difluoro-N-(2-hydroxyethoxy)benzamide, is administered to treat arthritis |
| 06/23/2005 | US20050137237 Triazolo-epothilones |
| 06/23/2005 | US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide |
| 06/23/2005 | US20050137214 Inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 06/23/2005 | US20050137192 Use of compounds such as 4-bromo-9a-butyl-8-chloro-6-fluoro-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one to treat depression |
| 06/23/2005 | US20050137188 Heterocyclic compounds |
| 06/23/2005 | US20050137180 Porphrins or azaporprins for photosensitizing therapy or photodetection with azaporprins for cardiovascular disorders and coordination with metals |
| 06/23/2005 | US20050137169 Vinca derivatives |
| 06/23/2005 | US20050137167 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; chemical intermediates; drug delivery |
| 06/23/2005 | US20050137158 Methods for targeting RNA molecules |
| 06/23/2005 | US20050137148 treating an infectious disease associated with narrowing or obstruction of a body passageway by delivering to an external portion of the body passageway an antibiotic; infections such as pelvic inflammatory disease, urethritis, or tuberculosis |
| 06/23/2005 | US20050137137 Inhibitors of the Interaction between p53 and MDM2 |
| 06/23/2005 | US20050136537 Modulating sirtuin deacetylase protein; apoptosis; using flavone, stilbene, isoflavone, sphingosine; stroke; cardiovascular disorders; antiarthritic agents; Alzheimer's disease |
| 06/23/2005 | US20050136494 Expression vector comprising nucleotide sequences coding immunoglobulin specific to transmembrane receptor for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 06/23/2005 | US20050136465 Screening assays |
| 06/23/2005 | US20050136403 Molecular characterists of non-small cell lung cancer |
| 06/23/2005 | US20050136402 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine |
| 06/23/2005 | US20050136162 Enzymatic treatment with intermittent wet milling; heat treating; centrifugation and ultrafiltration separation; high value protein, fat, sugar, fiber and phytate fractions of distinct properties; low cost |
| 06/23/2005 | US20050136132 Aqueous organic solvent extract of trigonellae, astragali, glehniae and asparagi |
| 06/23/2005 | US20050136074 Administering antigens capable of causing specific immune reaction(s) directed against an infectious agent and/or cells infected with the infectious agent, and decreasing a different specific immune reaction direct towards the infectious agent, infected cells and/or uninfected cells; immunotherapy |
| 06/23/2005 | DE60108272T2 Pharmazeutische zusammensetzung enthaltend (-)-secoisolariciresinol A pharmaceutical composition comprising (-) - Secoisolariciresinol |
| 06/23/2005 | CA2549384A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 06/23/2005 | CA2549291A1 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 06/23/2005 | CA2548929A1 Cell death inducing agent |
| 06/23/2005 | CA2548901A1 Use of goat blood serum derived antibodies obtained after challenge with hiv lysate for veterinary treatment |
| 06/23/2005 | CA2548605A1 Chp-gemcitabin combined agent and use thereof as anti-tumoural active substances |
| 06/23/2005 | CA2548443A1 Use of chp as an inhibitor of glutathione s-transferases and collagen iv |
| 06/23/2005 | CA2548172A1 Quinoxalines useful as inhibitors of protein kinases |
| 06/23/2005 | CA2548011A1 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds as ikk inhibitors |
| 06/23/2005 | CA2547922A1 Viral particles containing an alphavirus-derived vector and method for preparing said viral particle |
| 06/23/2005 | CA2547863A1 Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy |
| 06/23/2005 | CA2547783A1 Methods for treating prostate cancer with herbal compositions |
| 06/23/2005 | CA2546920A1 Methods for suppressing an immune response or treating a proliferative disorder |
| 06/23/2005 | CA2546057A1 Method to improve the efficacy of therapeutic radiolabeled drugs |
| 06/23/2005 | CA2490218A1 Extracorporeal photopheresis in combination with anti-tnf treatment |
| 06/22/2005 | EP1544299A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 06/22/2005 | EP1544281A1 Fat composition |
| 06/22/2005 | EP1543834A1 Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1543008A1 Imidazopyrazines as cyclin dependent kinase inhibitors |
| 06/22/2005 | EP1543001A1 Novel pyrazolopyridine derivatives as pharmaceutical agents |
| 06/22/2005 | EP1542997A2 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents |
| 06/22/2005 | EP1542995A1 Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1542994A1 Novel triazole and oxazole compounds as transforming growth factor (tgf) inhibitor |
| 06/22/2005 | EP1542990A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1542989A1 Protein tyrosine kinase inhibitors |
| 06/22/2005 | EP1542978A1 Novel bio-active molecules |
| 06/22/2005 | EP1542977A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 06/22/2005 | EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |